Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New sigma-receptor ligands presented by Sumitomo

Nov. 5, 1998

GlyT-1 technology forms the basis of Allelix and Janssen neuropsychiatric collaboration

Nov. 4, 1998

Meiji Seika discloses new neuroprotective substance isolated from fungus

Nov. 4, 1998

Novel isoquinoline anticonvulsants in development at SB

Nov. 4, 1998

Entropin concentrates its efforts on bringing Esterom to market

Nov. 4, 1998

Monoamine reuptake inhibitors especially useful for Parkinson's disease

Nov. 3, 1998

Positive CPMP opinion issued for Betaseron in new indication

Nov. 2, 1998

Licensing opportunity from the NIH: method of protecting neural cells from apoptosis

Nov. 2, 1998

Tacrolimus may represent novel neurotrophic strategy for neurodegenerative disorders

Oct. 30, 1998

Intravenous N-0923 associated with rapid onset and short-lasting antiparkinsonian effects

Oct. 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....